Search Results for 'Svr12-0938'

Svr12-0938 published presentations and documents on DocSlides.

Sofosbuvir, Ribavirin, GS

Sofosbuvir, Ribavirin, GS

by min-jolicoeur

-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...

by alida-meadow

1. Le 29-01-2015. Les anticorps neutralisants ant...

TURQUOISE II: Genotype 1a SVR12 Based on Prior Treatment Source: Poord

TURQUOISE II: Genotype 1a SVR12 Based on Prior Treatment Source: Poord

by stefany-barnette

TURQUOISE II: Genotype 1b SVR12 Based on Prior Tre...

Gemeinde Michelau Ferienspaß

Gemeinde Michelau Ferienspaß

by stylerson

2012. Teilnahme:. Alle Schulkinder von 6 – 16...

Acknowledgements : This research is supported by NSF grant 0938074

Acknowledgements : This research is supported by NSF grant 0938074

by lois-ondreau

Acknowledgements : This research is supported by ...

Application for Exemption for American Indians and Alaska Natives and Other Individuals who are Eligible to Receive Services from an Indian Health Care Provider THINGS TO KNOW Form Approved OMB No

Application for Exemption for American Indians and Alaska Natives and Other Individuals who are Eligible to Receive Services from an Indian Health Care Provider THINGS TO KNOW Form Approved OMB No

by tatiana-dople

09381190 Use this application to apply for an exe...

DEP DEP AR AR TMENT TMENT OF HEAL OF HEAL TH TH AND HUMAN SER AND HUMAN SER VICES VICES Form Approved Form Approved CENTERS FOR MEDICARE MEDICAID SER CENTERS FOR MEDICARE MEDICAID SER VICES VICE

DEP DEP AR AR TMENT TMENT OF HEAL OF HEAL TH TH AND HUMAN SER AND HUMAN SER VICES VICES Form Approved Form Approved CENTERS FOR MEDICARE MEDICAID SER CENTERS FOR MEDICARE MEDICAID SER VICES VICE

by mitsue-stanley

09380600 OMB No 0938060057375 MEDICARE CREDIT BAL...

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE MEDICAID SERVICES Form Approved OMB No

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE MEDICAID SERVICES Form Approved OMB No

by pamella-moone

0938 1230 APPLICATION FOR ENROLLMENT IN MEDICARE ...

Form CMS DEPARTMENT OF HEALTH AND HUMAN SERVICES CE

Form CMS DEPARTMENT OF HEALTH AND HUMAN SERVICES CE

by faustina-dinatale

09380626 ELECTRONIC FUNDS TRANSFER EFT AUTHORIZAT...

Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation

Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation

by ahmir653

SOLAR-2. Source: . Manns. M, et al. Lancet Infect...

Safety and Efficacy of Daclatasvir

Safety and Efficacy of Daclatasvir

by tabitha

. Plus . Sofosbuvir. With or Without Ribavirin . ...

Elbasvir-Grazoprevir in

Elbasvir-Grazoprevir in

by esther

HCV . GT 1,4, or 6 in PWID* on Opiate Agonist Ther...

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

by sophia2

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

C-EDGE Co-Infected: Phase 3 Study of

C-EDGE Co-Infected: Phase 3 Study of

by giovanna-bartolotta

C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

by pasty-toler

ASTRAL-1. Phase 3. . Treatment. . Naïve & ...

Single arm Open label ≥

Single arm Open label ≥

by ellena-manuel

18 years. BMI ≥ 18 kg/m. 2. HCV genotype 2, 4, ...

SMV 150 mg QD SOF 400 mg QD

SMV 150 mg QD SOF 400 mg QD

by alida-meadow

Randomisation. 1 : 1. 18-70 years. HCV genotype 1...

Sofosbuvir-Velpatasvir in Genotype 2

Sofosbuvir-Velpatasvir in Genotype 2

by stefany-barnette

ASTRAL-2*. Phase 3. . Treatment. . Naïve &...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by trish-goza

in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...

by debby-jeon

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

by faustina-dinatale

Open label. ≥ . 18 years. HCV genotype 4, 5 or...

by conchita-marotz

Open-label. Chronic HCV infection. Genotype 1 . F...

Sofosbuvir in Genotypes 2 or 3

Sofosbuvir in Genotypes 2 or 3

by giovanna-bartolotta

VALENCE Trial. Phase . 3. Treatment. Naïve and ...

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

by min-jolicoeur

Randomisation. Open-label. W8. * Liver biopsy or ...

by celsa-spraggs

400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

by lois-ondreau

3. Rd. International . HIV/Hepatitis . Coinfecti...

Sofosbuvir in HCV-

Sofosbuvir in HCV-

by mitsue-stanley

HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...

by olivia-moreira

. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...

by alida-meadow

versus . Telaprevir. . with PR in GT1 . ATTAIN ...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by jane-oiler

(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...

by trish-goza

+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...

by ellena-manuel

Genotype . 1 . (. Viral . Relapsers. ). PROMISE ....

Daclatasvir in Combination With Sofosbuvir

Daclatasvir in Combination With Sofosbuvir

by mitsue-stanley

With Or Without Ribavirin Is Safe and Efficacious...

by giovanna-bartolotta

+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...

by tatyana-admore

. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...

by conchita-marotz

ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

3D (Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir) + RBV in

by yoshiko-marsland

TURQUOISE-II. Phase 3. . Treatment. Naïve and ...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...